Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomised, double-blind, placebo-controlled, 3-period cross-over study to evaluate the effect of two doses of GSK2190915 on the allergen-induced early asthmatic response in subjects with mild asthma
fiboflapon
LPA112356
NCT00812773
Asthma
Phase 2
 
June 2015

Powered by ideaPoint, Inc.